You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
|
|---|---|
| Published in |
New England Journal of Medicine, June 2019
|
| DOI | 10.1056/nejmoa1902226 |
| Pubmed ID | |
| Authors |
Kevan C Herold, Brian N Bundy, S Alice Long, Jeffrey A Bluestone, Linda A DiMeglio, Matthew J Dufort, Stephen E Gitelman, Peter A Gottlieb, Jeffrey P Krischer, Peter S Linsley, Jennifer B Marks, Wayne Moore, Antoinette Moran, Henry Rodriguez, William E Russell, Desmond Schatz, Jay S Skyler, Eva Tsalikian, Diane K Wherrett, Anette-Gabriele Ziegler, Carla J Greenbaum |
X Demographics
The data shown below were collected from the profiles of 600 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 161 | 27% |
| United Kingdom | 55 | 9% |
| Spain | 37 | 6% |
| Canada | 15 | 3% |
| Mexico | 12 | 2% |
| Saudi Arabia | 12 | 2% |
| France | 10 | 2% |
| Australia | 9 | 2% |
| Japan | 9 | 2% |
| Other | 80 | 13% |
| Unknown | 200 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 376 | 63% |
| Scientists | 144 | 24% |
| Practitioners (doctors, other healthcare professionals) | 62 | 10% |
| Science communicators (journalists, bloggers, editors) | 18 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 701 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 701 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 88 | 13% |
| Student > Bachelor | 85 | 12% |
| Student > Ph. D. Student | 76 | 11% |
| Student > Master | 50 | 7% |
| Other | 38 | 5% |
| Other | 114 | 16% |
| Unknown | 250 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 154 | 22% |
| Biochemistry, Genetics and Molecular Biology | 76 | 11% |
| Immunology and Microbiology | 51 | 7% |
| Agricultural and Biological Sciences | 29 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 21 | 3% |
| Other | 100 | 14% |
| Unknown | 270 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1155. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 March 2024.
All research outputs
#12,924
of 25,766,791 outputs
Outputs from New England Journal of Medicine
#574
of 32,674 outputs
Outputs of similar age
#199
of 369,106 outputs
Outputs of similar age from New England Journal of Medicine
#4
of 268 outputs
Altmetric has tracked 25,766,791 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,674 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.9. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 369,106 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 268 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.